by Benjamin H. Rudolph, Aptagen, Inc. Having a big name on your team isn't enough, but it sure helps!
Benjamin H. Rudolph
Advertisement
Articles by Benjamin H. Rudolph
by Benjamin H. Rudolph, Aptgen, Inc. What's an investor to do when previously rock-solid investments suddenly aren't?
by Benjamin H. Rudolph and Viqar Aslam, Aptagen, Inc. One company shows the world that stem cell research isn't coing away -- and receives a worldwide ctroversy in the process.
Advertisement
Latest Updated Articles
- Your Vested Interests: The War of the West
Published: January 15th 2002 | Updated:
- The Not-So-Sure Thing
Published: May 15th 2002 | Updated:
- Your Vested Interests: Gorillas In Our Midst
Published: August 15th 2002 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
3
Everything to Know About Cell and Gene Therapy in 2025
4
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
5
